Since vitamin D supplementation had no effects on PMI values and the development of sarcopenia, the following survival analyses were not compared between the vitamin D group and the placebo group, but they were compared either between the SPARC lower and the SPARC higher than median groups, or between the absence and presence of sarcopenia at diagnosis. The gene discussed is SPARC; the disease is sarcopenia.